|Articles|May 15, 2021
- Pharmaceutical Technology-05-15-2021
- Volume 2021 eBook
- Issue 2
Reducing Packaging Costs for Prefilled Syringes
Author(s)Beth Totin, Marcus Webb
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines.
Advertisement
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines. Currently used for over-the-counter products, prescription medicines, and more than 50 injectable products, the authors present the case for using BFS for prefilled syringes. Factors including drug formulation, material compatibility, extractables and leachables, sterilization, and regulatory approval must be considered.
About the authors
Beth Totin is chief commercial officer, and Marcus Webb is director of communications, both with ApiJect Systems, Corp.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 54–59
Citation
When referring to this article, please cite it as B. Totin and M. Webb, “Reducing Packaging Costs for Prefilled Syringes," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Articles in this issue
over 4 years ago
Sterile Filtration: Reducing Risk, Ensuring Safetyover 4 years ago
Filling Small Batchesover 4 years ago
Breaking the Cold Chain for Vaccinesover 4 years ago
Using ddPCR to Detect Mycoplasma Contaminationover 4 years ago
The Impact of COVID-19 on Biologics Regulationsover 4 years ago
Packaging Biologic Drugs for Clinical Trialsover 4 years ago
Tracking Technologies Guard Vaccine Cold Chainover 4 years ago
Eyeing Up Success in Fill/Finishover 4 years ago
Biologics Facilities Expand and Establish New Locations in 2021Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
